Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mossad

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|September 5, 2002
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilizationR K Avery, B L Pohlman, S B Mossad, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 10, 2019
Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: A multicenter study from the congenital catheterization research collaborativeHolly Bauser-Heaton, Athar M Qureshi, Bryan H Goldstein, et al.
Bone Marrow Transplantation|October 19, 2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.
Transplantation|August 5, 2010
Utility of leflunomide in the treatment of complex cytomegalovirus syndromesRobin K Avery, Sherif B Mossad, Emilio Poggio, et al.
World Journal of Transplantation|July 18, 2014
Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsChristopher S Kovacs, Christine E Koval, David van Duin, et al.
Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 22, 2003
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infectionC M Isada, B Yen-Lieberman, N S Lurain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2020
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT StudyRoy F Chemaly, Lynn El Haddad, Drew J Winston, et al.
Open Forum Infectious Diseases|August 28, 2023
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell TransplantElla J Ariza-Heredia, Drew J Winston, Scott D Rowley, et al.
Open Forum Infectious Diseases|February 12, 2021
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal AgentsMatthew A Miller, Kyle C Molina, Jonathan A Gutman, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|September 5, 2002
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilizationR K Avery, B L Pohlman, S B Mossad, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 10, 2019
Use of carotid and axillary artery approach for stenting the patent ductus arteriosus in infants with ductal-dependent pulmonary blood flow: A multicenter study from the congenital catheterization research collaborativeHolly Bauser-Heaton, Athar M Qureshi, Bryan H Goldstein, et al.
Bone Marrow Transplantation|October 19, 2004
Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionR K Avery, B J Bolwell, B Yen-Lieberman, et al.
Transplantation|August 5, 2010
Utility of leflunomide in the treatment of complex cytomegalovirus syndromesRobin K Avery, Sherif B Mossad, Emilio Poggio, et al.
World Journal of Transplantation|July 18, 2014
Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infectionsChristopher S Kovacs, Christine E Koval, David van Duin, et al.
Blood|September 20, 2014
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipientsEdward A Stadtmauer, Keith M Sullivan, Francisco M Marty, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 22, 2003
Clinical characteristics of 13 solid organ transplant recipients with ganciclovir-resistant cytomegalovirus infectionC M Isada, B Yen-Lieberman, N S Lurain, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 21, 2020
Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT StudyRoy F Chemaly, Lynn El Haddad, Drew J Winston, et al.
Open Forum Infectious Diseases|August 28, 2023
Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell TransplantElla J Ariza-Heredia, Drew J Winston, Scott D Rowley, et al.
Open Forum Infectious Diseases|February 12, 2021
Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal AgentsMatthew A Miller, Kyle C Molina, Jonathan A Gutman, et al.
Pageof 13